ReviewFrontiers in oncology2024

Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer.

Marjorie A ShapiroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.